|
1
|
Jaffe N, Bruland OS and Bielack S:
Pediatric and Adolescent Osteosarcoma. Springer; pp. 152Berlin:
2010
|
|
2
|
Hou CH, Lin FL, Tong KB, Hou SM and Liu
JF: Transforming growth factor alpha promotes osteosarcoma
metastasis by ICAM-1 and PI3K/Akt signaling pathway. Biochem
Pharmacol. 89:453–463. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dong Y, Liang G, Yuan B, Yang C, Gao R and
Zhou X: MALAT1 promotes the proliferation and metastasis of
osteosarcoma cells by activating the PI3K/Akt pathway. Tumour Biol.
36:1477–1486. 2015. View Article : Google Scholar
|
|
4
|
Guo YS, Zhao R, Ma J, Cui W, Sun Z, Gao B,
He S, Han YH, Fan J, Yang L, et al: βig-h3 promotes human
osteosarcoma cells metastasis by interacting with integrin α2β1 and
activating PI3K signaling pathway. PLoS One. 9:e902202014.
View Article : Google Scholar
|
|
5
|
Liao D, Zhong L, Duan T, Zhang RH, Wang X,
Wang G, Hu K, Lv X and Kang T: Aspirin suppresses the growth and
metastasis of osteosarcoma through the NF-κB pathway. Clin Cancer
Res. 21:5349–5359. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang P, Yang Y, Zweidler-McKay P and
Hughes DPM: Retraction: Critical role of notch signaling in
osteosarcoma invasion and metastasis. Clin Cancer Res.
19:5256–5257. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guan G, Zhang Y, Lu Y, Liu L, Shi D, Wen
Y, Yang L, Ma Q, Liu T, Zhu X, et al: The HIF-1α/CXCR4 pathway
supports hypoxia-induced metastasis of human osteosarcoma cells.
Cancer Lett. 357:254–264. 2015. View Article : Google Scholar
|
|
8
|
Khanna C, Wan X, Bose S, Cassaday R, Olomu
O, Mendoza A, Yeung C, Gorlick R, Hewitt SM and Helman LJ: The
membrane-cytoskeleton linker ezrin is necessary for osteosarcoma
metastasis. Nat Med. 10:182–186. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ren L, Hong SH, Cassavaugh J, Osborne T,
Chou AJ, Kim SY, Gorlick R, Hewitt SM and Khanna C: The
actin-cytoskeleton linker protein ezrin is regulated during
osteosarcoma metastasis by PKC. Oncogene. 28:792–802. 2009.
View Article : Google Scholar
|
|
10
|
Wan X, Kim SY, Guenther LM, Mendoza A,
Briggs J, Yeung C, Currier D, Zhang H, Mackall C, Li WJ, et al:
Beta4 integrin promotes osteosarcoma metastasis and interacts with
ezrin. Oncogene. 28:3401–3411. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Long F, Cai X, Luo W, Chen L and Li K:
Role of aldolase A in osteosarcoma progression and metastasis: In
vitro and in vivo evidence. Oncol Rep. 32:2031–2037. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qu L and Liu B: Cyclooxygeanse-2 promotes
metastasis in osteosarcoma. Cancer Cell Int. 15:692015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Su Y, Wagner ER, Luo Q, Huang J, Chen L,
He BC, Zuo GW, Shi Q, Zhang BQ, Zhu G, et al: Insulin-like growth
factor binding protein 5 suppresses tumor growth and metastasis of
human osteosarcoma. Oncogene. 30:3907–3917. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Namløs HM, Kresse SH, Müller CR, Henriksen
J, Holdhus R, Sæter G, Bruland OS, Bjerkehagen B, Steen VM and
Myklebost O: Global gene expression profiling of human
osteosarcomas reveals metastasis-associated chemokine pattern.
Sarcoma. 2012:6390382012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Odagiri H, Kadomatsu T, Endo M, Masuda T,
Morioka MS, Fukuhara S, Miyamoto T, Kobayashi E, Miyata K, Aoi J,
et al: The secreted protein ANGPTL2 promotes metastasis of
osteosarcoma cells through integrin α5β1, p38 MAPK, and matrix
metalloproteinases. Sci Signal. 7:ra72014. View Article : Google Scholar
|
|
16
|
Endo-Munoz L, Cumming A, Rickwood D,
Wilson D, Cueva C, Ng C, Strutton G, Cassady AI, Evdokiou A,
Sommerville S, et al: Loss of osteoclasts contributes to
development of osteosarcoma pulmonary metastases. Cancer Res.
70:7063–7072. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Buddingh EP, Kuijjer ML, Duim RA, Bürger
H, Agelopoulos K, Myklebost O, Serra M, Mertens F, Hogendoorn PC,
Lankester AC, et al: Tumor-infiltrating macrophages are associated
with metastasis suppression in high-grade osteosarcoma: A rationale
for treatment with macrophage activating agents. Clin Cancer Res.
17:2110–2119. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Smyth GK: Limma: Linear Models for
Microarray Data. Bioinformatics and Computational Biology Solutions
Using R and Bioconductor. Gentleman R, Carey VJ, Huber W, Irizarry
RA and Dudoit S: Springer; New York, NY: pp. 397–420. 2005,
View Article : Google Scholar
|
|
19
|
Wang X, Kang DD, Shen K, Song C, Lu S,
Chang LC, Liao SG, Huo Z, Tang S, Ding Y, et al: An R package suite
for microarray meta-analysis in quality control, differentially
expressed gene analysis and pathway enrichment detection.
Bioinformatics. 28:2534–2536. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chatr-Aryamontri A, Breitkreutz BJ,
Oughtred R, Boucher L, Heinicke S, Chen D, Stark C, Breitkreutz A,
Kolas N, O'Donnell L, et al: The BioGRID interaction database: 2015
update. Nucleic Acids Res. 43:D470–D478. 2015. View Article : Google Scholar :
|
|
21
|
Keshava Prasad TS, Goel R, Kandasamy K,
Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R,
Shafreen B, Venugopal A, et al: Human Protein Reference Database –
2009 update. Nucleic Acids Res. 37:D767–D772. 2009. View Article : Google Scholar
|
|
22
|
Xenarios I, Rice DW, Salwinski L, Baron
MK, Marcotte EM and Eisenberg D: DIP: The database of interacting
proteins. Nucleic Acids Res. 28:289–291. 2000. View Article : Google Scholar
|
|
23
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar :
|
|
24
|
Kim HS, Park YB, Oh JH, Jeong J, Kim CJ
and Lee SH: Expression of CD44 isoforms correlates with the
metastatic potential of osteosarcoma. Clin Orthop Relat Res.
396:184–190. 2002. View Article : Google Scholar
|
|
25
|
Zhao H, Ma B, Wang Y, Han T, Zheng L, Sun
C, Liu T, Zhang Y, Qiu X and Fan Q: miR-34a inhibits the metastasis
of osteosarcoma cells by repressing the expression of CD44. Oncol
Rep. 29:1027–1036. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fritsche-Guenther R, Noske A, Ungethüm U,
Kuban RJ, Schlag PM, Tunn PU, Karle J, Krenn V, Dietel M and Sers
C: De novo expression of EphA2 in osteosarcoma modulates activation
of the mitogenic signalling pathway. Histopathology. 57:836–850.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Posthumadeboer J, Piersma SR, Pham TV, van
Egmond PW, Knol JC, Cleton-Jansen AM, van Geer MA, van Beusechem
VW, Kaspers GJ, van Royen BJ, et al: Surface proteomic analysis of
osteosarcoma identifies EPHA2 as receptor for targeted drug
delivery. Br J Cancer. 109:2142–2154. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liang G, Xu E, Yang C, Zhang C, Sheng X
and Zhou X: Nucleosome-binding protein HMGN2 exhibits antitumor
activity in human SaO2 and U2-OS osteosarcoma cell lines. Oncol
Rep. 33:1300–1306. 2015. View Article : Google Scholar
|
|
29
|
Yang J, Annala M, Ji P, Wang G, Zheng H,
Codgell D, Du X, Fang Z, Sun B, Nykter M, et al: Recurrent
LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell
motility in human osteosarcoma. J Hematol Oncol. 7:762014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang J, Xu G, Shen F and Kang Y: miR-132
targeting cyclin E1 suppresses cell proliferation in osteosarcoma
cells. Tumour Biol. 35:4859–4865. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu J, Gu J, Feng Z, Yang Y, Zhu N, Lu W
and Qi F: Both HDAC5 and HDAC6 are required for the proliferation
and metastasis of melanoma cells. J Transl Med. 14:72016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang XC, Ma Y, Meng PS, Han JL, Yu HY and
Bi LJ: miR-433 inhibits oral squamous cell carcinoma (OSCC) cell
growth and metastasis by targeting HDAC6. Oral Oncol. 51:674–682.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo DL, Zhang J, Yuen ST, Tsui WY, Chan
AS, Ho C, Ji J, Leung SY and Chen X: Reduced expression of EphB2
that parallels invasion and metastasis in colorectal tumours.
Carcinogenesis. 27:454–464. 2006. View Article : Google Scholar
|
|
34
|
Oshima T, Akaike M, Yoshihara K, Shiozawa
M, Yamamoto N, Sato T, Akihito N, Nagano Y, Fujii S, Kunisaki C, et
al: Overexpression of EphA4 gene and reduced expression of EphB2
gene correlates with liver metastasis in colorectal cancer. Int J
Oncol. 33:573–577. 2008.PubMed/NCBI
|
|
35
|
Feng X, Wu Z, Wu Y, Hankey W, Prior TW, Li
L, Ganju RK, Shen R and Zou X: Cdc25A regulates matrix
metalloprotease 1 through Foxo1 and mediates metastasis of breast
cancer cells. Mol Cell Biol. 31:3457–3471. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zurita M, Lara PC, del Moral R, Torres B,
Linares-Fernández JL, Arrabal SR, Martínez-Galán J, Oliver FJ and
Ruiz de Almodóvar JM: Hypermethylated 14-3-3-σ and ESR1 gene
promoters in serum as candidate biomarkers for the diagnosis and
treatment efficacy of breast cancer metastasis. BMC Cancer.
10:2172010. View Article : Google Scholar
|
|
37
|
Sonaglio V, de Carvalho AC, Toledo SR,
Salinas-Souza C, Carvalho AL, Petrilli AS, de Camargo B and Vettore
AL: Aberrant DNA methylation of ESR1 and 14ARF genes could be
useful as prognostic indicators in osteosarcoma. Onco Targets Ther.
6:713–723. 2013.
|
